share_log

CVS Health | 13F-HR: Information required of institutional investment managers pursuant to Section 13(f)

CVS Health | 13F-HR: Information required of institutional investment managers pursuant to Section 13(f)

西維斯健康 | 13F-HR:投資機構季度報告
美股SEC公告 ·  05/04 04:32

牛牛AI助理已提取核心訊息

CVS Health Corp has submitted its Form 13F filing to the Securities and Exchange Commission (SEC) for the first quarter ended March 31, 2024. The filing, signed by Investment Manager Michael Motolo on May 3, 2024, in Woonsocket, RI, includes a total of 6 holdings with a combined value of $211,778,622. The Form 13F filing, which is a quarterly report filed by institutional investment managers to disclose their U.S. equity holdings, indicates that CVS Health Corp is the sole reporting manager for these holdings, as no other included managers are listed in the report.
CVS Health Corp has submitted its Form 13F filing to the Securities and Exchange Commission (SEC) for the first quarter ended March 31, 2024. The filing, signed by Investment Manager Michael Motolo on May 3, 2024, in Woonsocket, RI, includes a total of 6 holdings with a combined value of $211,778,622. The Form 13F filing, which is a quarterly report filed by institutional investment managers to disclose their U.S. equity holdings, indicates that CVS Health Corp is the sole reporting manager for these holdings, as no other included managers are listed in the report.
CVS Health Corp已向美國證券交易委員會(SEC)提交了截至2024年3月31日的第一季度的13F表格。該文件由投資經理邁克爾·莫託洛於2024年5月3日在羅得島州文索克特簽署,共包括6筆持股,總價值爲211,778,622美元。13F表文件是機構投資經理爲披露其持有的美國股票而提交的季度報告。該文件表明,CVS Health Corp是這些持股的唯一申報管理公司,因爲報告中沒有列出其他納入的管理公司。
CVS Health Corp已向美國證券交易委員會(SEC)提交了截至2024年3月31日的第一季度的13F表格。該文件由投資經理邁克爾·莫託洛於2024年5月3日在羅得島州文索克特簽署,共包括6筆持股,總價值爲211,778,622美元。13F表文件是機構投資經理爲披露其持有的美國股票而提交的季度報告。該文件表明,CVS Health Corp是這些持股的唯一申報管理公司,因爲報告中沒有列出其他納入的管理公司。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。